cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Harpoon Therapeutics Inc
14 own
21 watching
Current Price
$1.02
$-0.08
(-7.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
33.89M
52-Week High
52-Week High
6.2
52-Week Low
52-Week Low
0.5857
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization33.89M
icon52-Week High6.2
icon52-Week Low0.5857
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio--
What does the Harpoon Therapeutics Inc do?
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body s immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Read More
How much money does Harpoon Therapeutics Inc make?
News & Events about Harpoon Therapeutics Inc.
Benzinga
1month ago
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. read more...
PR Newswire
1month ago
Thinking about buying stock in HTG Molecular Diagnostics, Harpoon Therapeutics, Acer Therapeutics, Aptevo Therapeutics, or Tonix Pharmaceuticals? Thinking about buying stock in HTG Molecular Diagnostics, Harpoon Therapeutics, Acer Therapeutics, Aptevo Therapeutics, or Tonix Pharmaceuticals? PR...
Globe Newswire
1month ago
Clinically active across a wide dose range (2.15 to 24 mg) in a Phase 1 trial of heavily pretreated patients with relapsed/refractory multiple myeloma77% (10/13) objective response rate (ORR) observed across highest doses (12 and 24 mg) Responses were durable, with many patients on treatment longer ...
Globe Newswire
3 months ago
Updated interim results from Phase 1 clinical trial of HPN217 in heavily pretreated patients with relapsed/refractory multiple myeloma to be presented in a poster at ASH on Sunday, December 11, 2022, from 6:00 p.m. 8:00 p.m. CTSOUTH SAN FRANCISCO, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Harpoon ...
Frequently Asked Questions
Frequently Asked Questions
What is Harpoon Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Harpoon Therapeutics Inc shares?
plus_minus_icon
How can I buy Harpoon Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Harpoon Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Harpoon Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Harpoon Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Harpoon Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Harpoon Therapeutics Inc?
plus_minus_icon
What percentage is Harpoon Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Harpoon Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.02
$-0.08
(-7.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00